Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,200 JPY | -0.78% | -3.47% | +25.98% |
May. 13 | Jefferies Adjusts CKD'S Price Target to 3,700 Yen From 4,000 Yen, Keeps at Buy | MT |
Apr. 15 | AstraZeneca: expects a sharp rise in kidney disease | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.98% | 1.38B | |
-7.04% | 15.35B | |
+33.02% | 5.31B | |
-2.34% | 5.21B | |
+2.43% | 5.18B | |
-20.43% | 4.46B | |
+12.70% | 4.39B | |
+10.41% | 3.98B | |
+45.02% | 3.87B | |
+1.66% | 3.37B |
- Stock Market
- Equities
- 6407 Stock
- News CKD Corporation
- Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD